Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArrow Explor. Regulatory News (AXL)

Share Price Information for Arrow Explor. (AXL)

Share Price is delayed by 15 minutes
Get Live Data
28.25    0.00 (0.00%)
Bid:
27.50
Ask:
29.00
Spread: 1.50 (5.455%)
Market Cap: £81.47m
AXL Live PriceLast checked at - London Stock Exchange

Intraday Arrow Explor. Share Chart

Holding(s) in Company

4 Mar 2022 14:59

RNS Number : 7381D
Arrow Exploration Corp.
04 March 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

CA04274P1053

Issuer Name

ARROW EXPLORATION CORP.

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

03-Mar-2022

6. Date on which Issuer notified

04-Mar-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.885200

3.861200

6.746400

14142159

Position of previous notification (if applicable)

4.698300

3.099400

7.797700

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

CA04274P1053

6048108

2.885200

Sub Total 8.A

6048108

2.885200%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

8094051

3.861200

Sub Total 8.B1

8094051

3.861200%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Matthew Allen01727895011

12. Date of Completion

04-Mar-2022

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUPUQAWUPPGCC
Date   Source Headline
27th May 20267:00 amRNSArrow Announces Q1 2026 Interim Results
26th May 20267:00 amRNSArrow Announces Exploration Well IC-1 Results
22nd May 20267:00 amRNS-RInvestor Presentation Via Investor Meet Company
13th May 20267:00 amRNSArrow Announces Exploration Well IC-1 Log Results
8th May 20267:00 amRNSArrow Announces Appraisal Well M-12 Results
5th May 20264:53 pmRNSTR-1: Notification of major holdings
29th Apr 20267:00 amRNSArrow Announces 2025 Year End and Q4 2025 Results
14th Apr 20265:32 pmRNSStandard form for notification of major holdings
1st Apr 20267:49 amRNSREPLACE - Arrow Appraisal Well M-11 Results
1st Apr 20267:00 amRNSArrow Announces Appraisal Well M-11 Results
25th Mar 20267:00 amRNSGrant and PDMR Exercise of Stock Options
20th Mar 20267:00 amRNSOperational Update and 2025 Year-End Reserves
2nd Mar 20267:00 amRNSArrow Announces Appraisal Wells M-9HZ, M-10 Result
28th Jan 20267:00 amRNSArrow Announces Appraisal Well M-8 Results
18th Dec 20257:00 amRNSArrow Announces Appraisal Well M-HZ7 Results
27th Nov 20257:00 amRNSArrow Announces Q3 2025 Interim Results
26th Nov 20257:00 amRNSARROW ANNOUNCES APPRAISAL WELL M-6 RESULTS
20th Nov 20257:00 amRNSAIM Rule 17 - Schedule 2(g) Update
12th Nov 20257:00 amRNSArrow Announces Exploration Well M-5 Results
9th Oct 20257:00 amRNSArrow Announces Grant of Stock Options
1st Oct 20257:00 amRNSArrow Announces Operational Update
25th Sep 20257:00 amRNSArrow Announces AGM Voting Results
9th Sep 20257:00 amRNSArrow Announces Operational Update
28th Aug 20257:00 amRNSArrow Announces Q2 2025 Interim Results
20th Aug 20257:00 amRNSArrow Announces Filing of AGM Materials
15th Jul 20257:00 amRNSOperational Update
9th Jul 20257:00 amRNSArrow Announces Resignation of Director
19th Jun 20257:00 amRNSPDMR Exercise and Grant of Options
13th Jun 20257:00 amRNSArrow Announces Normal Course Issuer Bid
30th May 20257:00 amRNSQ1 2025 Interim Results and Operational Update
29th Apr 20257:00 amRNSArrow Announces 2024 Year End and Q4 2024 Results
10th Apr 20257:00 amRNSOPERATIONAL UPDATE
13th Mar 20257:00 amRNS2024 Year-End Reserves Update
5th Feb 20257:00 amRNSArrow Announces Update on AB Wells
6th Jan 20257:00 amRNSArrow Announces Exploration Well AB-1 Results
17th Dec 20247:00 amRNSAB-1 Exploration Well Update
28th Nov 20247:00 amRNSQ3 2024 Interim Results
11th Nov 20247:00 amRNSFifth Ubaque Horizontal Well Results
27th Sep 20247:00 amRNSArrow Announces AGM Voting Results
23rd Sep 20247:00 amRNSFourth Ubaque Horizontal Well Results
12th Sep 20247:00 amRNSArrow Announces Grant of Stock Options
29th Aug 20247:00 amRNSThird Horizontal Well Results and Q2 2024 Results
21st Aug 20247:00 amRNSArrow Announces Filing of AGM Materials
14th Aug 20247:01 amRNSTR-1: Notification of major holdings
14th Aug 20247:00 amRNSTR-1: Notification of major holdings
31st Jul 20247:00 amRNSSecond Ubaque Horizontal Well Results
4th Jul 20247:00 amRNSPDMR Exercise of Options
21st Jun 20247:00 amRNSDirector/PDMR Shareholding
19th Jun 20247:00 amRNSFirst Ubaque Horizontal Well Results
4th Jun 20247:00 amRNSReplacement - Q1 2024 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.